Articles

View all articles

View all articles

Aims and scope

Transplantation Research is an open access journal that publishes articles on a broad range of topics in the discipline of transplantation. The content of this journal is directed towards both basic scientists and clinicians in this field, with the aim of informing all transplantation researchers and those interested in transplantation.

Among the research topics included in Transplantation Research are:

  • Organ preservation
  • Ischemia-reperfusion injury and inflammation
  • Histocompatibility
  • Pharmacological/experimental immunosuppression
  • Immune recognition - regulation, and tolerance induction strategies
  • Stem cell research for tissue regeneration/repair and immune regulation, and organ fabrication
  • Early-stage clinical trials and clinical trial protocols
  • Innovative method protocols
  • Complications of transplantation, including graft dysfunction, tissue repair, infections and post- transplant malignancy
  • Biomarker investigation
  • Organ donation and other ethical issues
  • Xenotransplantation

Types of transplantation primarily included are thoracic (heart and lung), abdominal (kidney, liver and pancreas) and tissue (islets, composite tissue).

 

Editor's profile

Prof Alan Jardine, Editor-in-Chief
Alan Jardine is a Clinical Professor of Renal Medicine at the University of Glasgow and Honorary Consultant in Medicine & Nephrology at the Western Infirmary in Glasgow. His research interests are in the cardiovascular and other long-term complications of renal disease and transplantation, and their pathophysiological determinants. He leads the Renal Research Group at the University of Glasgow, with ongoing research ranging from laboratory based studies on cardiac and vascular function, to international, multicentre trials. His involvement in the leadership of clinical trials includes some of the first large scale studies to investigate cardiovascular outcomes in this patient group, as well as studies on immunosuppression and anti-viral agents.


Advertisement